A Washington, D.C. federal appeals court has extended drugmaker filing deadlines and has pushed back oral arguments in litigation surrounding HRSA's authority to approve 340B rebates.

Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

August 28, 2025 William Newton, Associate Editor/Senior Writer Views

A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Staff Email

Site Footer Live